Cancer immunotherapy
- Submission status
- Open
- Submission deadline
Recent advances in immunotherapy have transformed the treatment of some cancers. However, not all patients respond to these treatments. There is an unmet clinical need to develop new and improved immunotherapies and identify efficacious combinations, with an increasing number of immunotherapy drugs in development and clinical trials. There is also a need to identify reliable predictive biomarkers of response and resistance to immunotherapy.
With this Collection, a partnership between Nature Communications, Communications Medicine and Scientific Reports, we welcome submissions of primary research papers that focus on cancer immunotherapy. We aim to reiterate the interest of the journals in publishing high-quality clinical research in the field of cancer immunotherapy. We also remain interested in preclinical studies proposing new immunotherapy strategies and combinatorial approaches, as well as novel immune cell engineering, nanotechnology and bio-engineering developments applied to cancer immunotherapy.
We will highlight relevant papers in this Collection; unfortunately, we cannot guarantee that any individual paper will be included in the Collection.
This Collection is open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of Communications Medicine, Nature Communications or Scientific Reports more generally.
All manuscripts will be considered for publication according to the editorial policies of the specific journal through which they are submitted, namely Communications Medicine, Nature Communications and Scientific Reports. In particular, all submissions are subject to the same peer review process and editorial standards as regular articles submitted to all participating journals, including the journal’s policy on competing interests. Visit Nature portfolio’s Collections guidelines for more details.
When submitting your manuscript to Communications Medicine, Nature Communications or Scientific Reports via our online submission system, please choose the appropriate Collection title from the drop-down menu on the submission form. Please be sure to express your interest in the Collection in your cover letter. Please only submit to one journal, but note authors have the option to transfer to another participating journal following the editors’ recommendation.
This Collection has not been supported by sponsorship.
